Allo HSCT Using RIC and PTCy for Hematological Diseases | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Allo HSCT Using RIC and PTCy for Hematological Diseases	B-cell chronic lymphocytic leukemia, B-cell neoplasm, Burkitt lymphoma, Chronic Disease, DNA Virus Infections, Disease Attributes, Epstein-Barr virus infection, Hemic and Lymphatic Diseases, Herpesviridae infectious disease, Infections, Leukemia, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Lymphoma, B-Cell, Marginal Zone, Myeloproliferative Disorders, Neoplasms by Histologic Type, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Precursor Cell Lymphoblastic Leukemia-Lymphoma, T-cell non-Hodgkin lymphoma, Tumor Virus Infections, acute biphenotypic leukemia, acute myeloid leukemia, bone marrow disorder, follicular lymphoma, hematologic disorder, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoid leukemia, lymphoma, lymphoproliferative syndrome, marginal zone lymphoma, myelodysplastic syndrome, myelodysplastic syndrome with excess blasts-1, myeloid leukemia, myeloproliferative neoplasm, neoplasm, plasma cell leukemia, plasma cell neoplasm, primary myelofibrosis, prolymphocytic leukemia, viral infectious disease	Recruiting	Phase 2	2026-07-06		NCT05805605

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Masonic Cancer Center, University of Minnesota	48

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Masonic Cancer Center at University of Minnesota	Minneapolis	United States	12